{
  "meta": {
    "title": "Vaccination_Mini_Test_-_Tmt",
    "url": "https://brainandscalpel.vercel.app/vaccination-mini-test-tmt-6e26730d.html",
    "scrapedAt": "2025-11-30T12:46:41.324Z"
  },
  "questions": [
    {
      "text": "Which of the following is a subunit vaccine?",
      "choices": [
        {
          "id": 1,
          "text": "BCG vaccine"
        },
        {
          "id": 2,
          "text": "Hepatitis B vaccine"
        },
        {
          "id": 3,
          "text": "DPT vaccine"
        },
        {
          "id": 4,
          "text": "IPV vaccine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Hepatitis B</strong> vaccine is an example of a <strong>subunit vaccine</strong> made using<strong> HBsAg.</strong></p>\n<p>Subunit vaccines are produced from macromolecules derived from immunogenic components of organisms by <strong>recombinant DNA technology. </strong>E.g., <strong>HPV vaccine</strong> (uses<strong> L1 major capsid protein</strong>) and hepatitis B vaccine (uses HBsAg). </p>\n<p>BCG is a live attenuated vaccine, IPV is an inactivated vaccine and DPT has diphtheria and tetanus toxoids and a killed pertussis component. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6013",
      "difficulty": "medium"
    },
    {
      "text": "In 2020, the U.S. Food and Drug Administration has approved Inmazeb , a mixture of three monoclonal antibodies, as the first FDA-approved treatment for which of the following deadly diseases?",
      "choices": [
        {
          "id": 1,
          "text": "Corona virus"
        },
        {
          "id": 2,
          "text": "Ebola virus"
        },
        {
          "id": 3,
          "text": "Lyssa virus"
        },
        {
          "id": 4,
          "text": "Nipah virus"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The U.S. Food and Drug Administration approved <strong>Inmazeb (atoltivimab, maftivimab, and odesivimab)</strong>, a mixture of three <strong>monoclonal antibodies</strong>, as the first FDA-approved treatment for <strong>Zaire ebolavirus </strong>(<strong>Ebola virus</strong>) infection in adult and pediatric patients.</p>\n<p>It is indicated for the treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Zaire ebolavirus infection.</p>\n<p>Inmazeb targets the <strong>glycoprotein</strong> that is on the surface of the Ebola virus. Glycoprotein attaches to the cell receptor and fuses the viral and host cell membranes allowing the virus to enter the cell. The three antibodies that makeup Inmazeb can bind to this glycoprotein simultaneously and <strong>block attachment and entry of the virus</strong></p>\n<p>Note: Patients who receive Inmazeb should avoid the concurrent administration of a live vaccine due to the treatment’s potential to inhibit replication of a live vaccine virus indicated for the prevention of Ebola virus infection and possibly reduce the vaccine’s efficacy.</p>\n<p><strong><span data-preserver-spaces=\"true\">Ebola virus </span></strong><span data-preserver-spaces=\"true\">is the cause of an emerging disease called Ebola virus disease and is widespread in Africa. It belongs to the </span><strong><span data-preserver-spaces=\"true\">Filoviridae</span></strong><span data-preserver-spaces=\"true\"> family.</span></p>\n<p><strong><span data-preserver-spaces=\"true\">Fruit bats</span></strong><span data-preserver-spaces=\"true\"> act as </span><strong><span data-preserver-spaces=\"true\">reservoir</span></strong><span data-preserver-spaces=\"true\"> hosts of the virus and it is transmitted to humans only accidentally. </span><strong><span data-preserver-spaces=\"true\">Human-to-human transmission</span></strong><span data-preserver-spaces=\"true\"> is through direct contact with blood or body fluids of an infected symptomatic person. </span></p>\n<p><span data-preserver-spaces=\"true\">The incubation period of the disease is </span><strong><span data-preserver-spaces=\"true\">2 to 21</span></strong><span data-preserver-spaces=\"true\"> days. Symptoms include </span><strong><span data-preserver-spaces=\"true\">fever, intense weakness, vomiting, diarrhea, rashes,</span></strong><span data-preserver-spaces=\"true\"> and, in extreme cases, internal and external </span><strong><span data-preserver-spaces=\"true\">bleeding</span></strong><span data-preserver-spaces=\"true\">. The current treatment is mainly supportive. Patients are susceptible to reinfection even after a complete cure.</span></p>\n<p> </p>\n<p><span data-preserver-spaces=\"true\">The electron micrograph image shows <strong>the Ebola virus</strong>.</span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/30a4a8bdef7a4c7bb1df5e10b02017a8x720x331.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD5726",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following vaccine is most sensitive to heat?",
      "choices": [
        {
          "id": 1,
          "text": "Japanese encephalitis vaccine"
        },
        {
          "id": 2,
          "text": "Measles vaccine"
        },
        {
          "id": 3,
          "text": "Oral polio vaccine"
        },
        {
          "id": 4,
          "text": "Pentavalent vaccine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Oral Polio Vaccine </strong>is the <strong>most</strong> <strong>heat-sensitive</strong> vaccine.<strong> </strong>Hence, it is kept in the <strong>lower zone </strong>of the Ice Lined Refrigerator.</p><hr><h3>Related Pearl: Temperature Sensitivity of Vaccines</h3><p><strong>Heat sensitivity</strong> in order of <strong>decreasing</strong> sensitivity:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>Group</td>\n<td>Vaccines</td>\n</tr>\n<tr>\n<td>A</td>\n<td>OPV</td>\n</tr>\n<tr>\n<td>B</td>\n<td>Influenza</td>\n</tr>\n<tr>\n<td>C</td>\n<td>\n<p>IPV</p>\n<p>Japanese encephalitis(live)</p>\n<p>Measles, mumps, rubella</p>\n</td>\n</tr>\n<tr>\n<td>D</td>\n<td>\n<p>Cholera</p>\n<p>DTaP</p>\n<p>Pentavalent</p>\n<p>Rotavirus</p>\n<p>Hib(liquid)</p>\n<p>Yellow fever</p>\n<p>Measles</p>\n<p>Rubella</p>\n</td>\n</tr>\n<tr>\n<td>E</td>\n<td>\n<p>BCG</p>\n<p>HPV</p>\n<p>Japanese encephalitis(inactivated)</p>\n<p>Tetanus, TD, Td</p>\n</td>\n</tr>\n<tr>\n<td>F</td>\n<td>\n<p>Hepatitis B</p>\n<p>Hib(freeze-dried)</p>\n<p>Meningococcal A</p>\n<p>Pneumococcal</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Vaccine <strong>sensitivity to freezing</strong>:</p>\n<p><strong>Rotavirus(liquid)</strong>&lt; T,DT,dT&lt; IPV &lt; Hib(liquid)&lt; HepB &lt; Pentavalent &lt;<strong>DTaP</strong></p>\n<p>Vaccines not damaged by freezing:</p>\n<ul>\n<li>Yellow fever</li>\n<li>BCG</li>\n<li>Hib</li>\n<li>Japanese encephalitis(live and inactivated)</li>\n<li>Measles, mumps, rubella</li>\n<li>OPV</li>\n<li>Rabies</li>\n<li>Rotavirus(Freeze-dried)</li>\n<li>Varicella zoster</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c7bd80ca927b42bcb0956bc12ae146b7x956x717.PNG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8669",
      "difficulty": "easy"
    },
    {
      "text": "You should perform a shake test prior to using all of the following vaccines, except ________.",
      "choices": [
        {
          "id": 1,
          "text": "OPV"
        },
        {
          "id": 2,
          "text": "TT"
        },
        {
          "id": 3,
          "text": "IPV"
        },
        {
          "id": 4,
          "text": "Hep B"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Only the <strong>injectable</strong>&nbsp;polio vaccine (IPV) is <strong>freeze sensitive</strong>, <strong>not the oral</strong>&nbsp;polio vaccine (OPV). Hence, a shake test is not relevant for OPV.</p>\n<p>The <strong>shake test</strong> is done to check for <strong>damage</strong> to vaccines that are sensitive to <strong>freezing temperatures.</strong></p>\n<p>Steps to perform the shake test:</p>\n<ul>\n<li>A <strong>frozen vaccine</strong> is used as a <strong>control vial</strong>, and the vial suspected to be damaged by freezing is taken as the test vial.</li>\n<li>Both are <strong>shaken after thawing</strong>,<strong>&nbsp;</strong>and the rate of <strong>sedimentation</strong> is <strong>compared</strong>.</li>\n<li>If the rate of <strong>sedimentation</strong> in the test vial is <strong>slower than</strong> that in the <strong>control</strong> vial, then it is <strong>usable</strong> and has not been damaged.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8e1d7fcab7b4460aa9557ded706a8a0dx600x796.JPEG\" alt=\"Explanation Image\"><p>Some of the most widely used&nbsp;<strong>vaccines</strong>&nbsp;are<strong>&nbsp;freeze sensitive</strong>:</p>\n<ul>\n<li>Hep B</li>\n<li>Pentavalent</li>\n<li>IPV</li>\n<li>DPT&nbsp;</li>\n<li>TT</li>\n<li>PCV</li>\n</ul>\n<p>Vaccines like OPV and rotavirus vaccines do not lose their potency and efficacy on freezing. Hence, these vaccines can be used again once they liquefy.</p><hr><h3>Related Pearl: Temperature Sensitivity of Vaccines</h3><p><strong>Heat sensitivity</strong> in order of <strong>decreasing</strong> sensitivity:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>Group</td>\n<td>Vaccines</td>\n</tr>\n<tr>\n<td>A</td>\n<td>OPV</td>\n</tr>\n<tr>\n<td>B</td>\n<td>Influenza</td>\n</tr>\n<tr>\n<td>C</td>\n<td>\n<p>IPV</p>\n<p>Japanese encephalitis(live)</p>\n<p>Measles, mumps, rubella</p>\n</td>\n</tr>\n<tr>\n<td>D</td>\n<td>\n<p>Cholera</p>\n<p>DTaP</p>\n<p>Pentavalent</p>\n<p>Rotavirus</p>\n<p>Hib(liquid)</p>\n<p>Yellow fever</p>\n<p>Measles</p>\n<p>Rubella</p>\n</td>\n</tr>\n<tr>\n<td>E</td>\n<td>\n<p>BCG</p>\n<p>HPV</p>\n<p>Japanese encephalitis(inactivated)</p>\n<p>Tetanus, TD, Td</p>\n</td>\n</tr>\n<tr>\n<td>F</td>\n<td>\n<p>Hepatitis B</p>\n<p>Hib(freeze-dried)</p>\n<p>Meningococcal A</p>\n<p>Pneumococcal</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Vaccine <strong>sensitivity to freezing</strong>:</p>\n<p><strong>Rotavirus(liquid)</strong>&lt; T,DT,dT&lt; IPV &lt; Hib(liquid)&lt; HepB &lt; Pentavalent &lt;<strong>DTaP</strong></p>\n<p>Vaccines not damaged by freezing:</p>\n<ul>\n<li>Yellow fever</li>\n<li>BCG</li>\n<li>Hib</li>\n<li>Japanese encephalitis(live and inactivated)</li>\n<li>Measles, mumps, rubella</li>\n<li>OPV</li>\n<li>Rabies</li>\n<li>Rotavirus(Freeze-dried)</li>\n<li>Varicella zoster</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c7bd80ca927b42bcb0956bc12ae146b7x956x717.PNG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5692",
      "difficulty": "medium"
    },
    {
      "text": "A child has come to you for the administration of the IPV vaccine, as part of his routine immunisation schedule. Which of the following antibiotics may be found in this vaccine?",
      "choices": [
        {
          "id": 1,
          "text": "Penicillin"
        },
        {
          "id": 2,
          "text": "Streptomycin"
        },
        {
          "id": 3,
          "text": "Amikacin"
        },
        {
          "id": 4,
          "text": "Erythromycin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>IPV</strong> may contain trace amounts of <strong>streptomycin</strong>, neomycin or polymyxin B. </p>\n<p>MMR contain small amount of neomycin. </p>\n<p>Antibiotics are used during vaccine manufacture to <strong>prevent bacterial contamination</strong> of tissue culture cells.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9455",
      "difficulty": "easy"
    },
    {
      "text": "A 20-day-old child who was not vaccinated at birth was brought to the OPD for vaccination. Which of the following vaccines can be administered to this child?<div class='question-desc-html'><ol>\n<li>BCG</li>\n<li>OPV-0</li>\n<li>HEP-B</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1,2"
        },
        {
          "id": 2,
          "text": "1,3"
        },
        {
          "id": 3,
          "text": "1"
        },
        {
          "id": 4,
          "text": "1,2,3"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The vaccine that can be administered to a 20-day-old child who was not vaccinated at birth is <strong>BCG.</strong></p>\n<p>The vaccines that are administered at birth are BCG, OPV-0, HEP-B</p>\n<ul>\n<li><strong>BCG</strong> can be administered till <strong>1 year of age</strong></li>\n<li><strong>OPV-0</strong> should be administered <strong>within 15 days</strong> after birth</li>\n<li><strong>HEP-B</strong> should be administered <strong>within 24 hours</strong> after birth</li>\n</ul><hr><h3>Related Pearl: National Immunization Schedule (India)</h3><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>When to give</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Route</strong></td>\n<td><strong>Site</strong></td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Pregnant Women</strong></td>\n</tr>\n<tr>\n<td>Td-1</td>\n<td>\n<p>Early in pregnancy</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-2</td>\n<td>\n<p>4 weeks after Td-1*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td- Booster</td>\n<td>\n<p>If received 2 Td doses in a pregnancy <br />within the last 3 yrs*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Infants</strong></td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>At birth or as early as possible until one year of age</p>\n</td>\n<td>0.1 mL (0.05 mL until<br />1 month<br />age)</td>\n<td>Intra-dermal</td>\n<td>Left upper arm</td>\n</tr>\n<tr>\n<td>Hepatitis B - Birth Dose</td>\n<td>\n<p>At birth or as early as possible within 24 hrs</p>\n</td>\n<td>0.5 mL</td>\n<td> Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>OPV - 0</td>\n<td>\n<p>At birth or as early as possible within the first 15 days</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>OPV-1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until 5 years of age)</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>Pentavalent 1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>0.5 mL</td>\n<td>lntra·muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>Rotavirus</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>5 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>IPV</td>\n<td>\n<p>Two fractional doses at 6, 14 weeks </p>\n</td>\n<td>0.1 mL</td>\n<td>Intra-dermal two fractional dose</td>\n<td>Intra-dermal: right Upper arm (at 6, 14 weeks)<br /><br /></td>\n</tr>\n<tr>\n<td>\n<p>PCV</p>\n<p>(wherever applicable)</p>\n</td>\n<td>\n<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra·muscular</td>\n<td>Antero-lateral side of mid-thigh, right</td>\n</tr>\n<tr>\n<td>Measles/MR 1<sup>st</sup> Dose</td>\n<td>\n<p>9 completed months to 12 months<br />(Can be given till 5 years of age)</p>\n</td>\n<td>0.5ml</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm</td>\n</tr>\n<tr>\n<td>JE- 1**</td>\n<td>\n<p>9 completed months to 12 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular(killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>\n<p>Anterolateral aspect of mid-thigh/Left upper arm </p>\n</td>\n</tr>\n<tr>\n<td>Vitamin A<br />(1st dose)</td>\n<td>\n<p>At 9 completed months with measles Rubella</p>\n</td>\n<td>1 mL (1 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Children </strong></td>\n</tr>\n<tr>\n<td>DPT booster-1</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh  </td>\n</tr>\n<tr>\n<td>Measles / MR 2<sup>nd </sup>dose</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm  </td>\n</tr>\n<tr>\n<td>OPV booster</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>JE-2</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular (killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>Anterolateral aspect of mid-thigh/Left upper arm </td>\n</tr>\n<tr>\n<td>Vitamin A***<br />(2nd to 9<sup>th</sup> dose)</td>\n<td>\n<p>16–18 months, followed by one dose every 6 months up to the age of 5 years</p>\n</td>\n<td>2 mL (2 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>DPT booster 2</td>\n<td>\n<p>5–6 years</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td</td>\n<td>10 years &amp; 16 years</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>\n<p>Upper arm</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>\n<p>**JE vaccine is introduced in select endemic districts after the campaigns. Intramuscular (killed inactivated) vaccine is gradually replacing the live attenuated vaccine. This change is because the killed vaccines are more effective and require fewer doses.</p>\n<p>***The 2nd to 9th doses of vitamin A can be administered to children 1–5 years old during biannual rounds, in collaboration with ICDS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8659",
      "difficulty": "hard"
    },
    {
      "text": "A 20-year old female patient presented with painless lesions on the vulva as shown in the image below. Which of the following vaccines is not protective against this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Gardasil"
        },
        {
          "id": 2,
          "text": "Cervarix"
        },
        {
          "id": 3,
          "text": "Gardasil-9"
        },
        {
          "id": 4,
          "text": "Quadrivalent HPV vaccine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The condition in the image is <strong>condyloma acuminata (venereal warts)</strong> caused by infection with human papilloma virus <strong>6 or 11.</strong> The Cervarix vaccine does not protect against it. <strong>Cervarix</strong> offers protection against HPV subtypes <strong>16,18</strong>, which cause CIN and Ca cervix.</p>\n<p>The image shows <strong>multiple warty growths </strong>on the vulva and around the anal canal, as seen in condyloma acuminata<strong>.</strong> The verrucous growths may appear discrete or coalesce to form large <strong>cauliflower-like </strong>growths. They may be asymptomatic but can also cause discomfort, discharge, or bleeding. Treatment may include <strong>ablation</strong>, <strong>excision</strong>, or <strong>topical agents</strong> such as podophyllin and imiquimod.</p>\n<p>The available vaccinations against HPV are summarized below.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Brand name</strong></td>\n<td><strong>Cervarix</strong></td>\n<td><strong>Gardasil</strong></td>\n<td><strong>Gardasil-9</strong></td>\n</tr>\n<tr>\n<td>Characteristic and HPV subtypes</td>\n<td>Bivalent:16,18</td>\n<td>Quadrivalent: <strong>6,11,</strong>16,18</td>\n<td>Nonavalent: <strong>6,11</strong>,16,18,31,33,45,52,58</td>\n</tr>\n<tr>\n<td>Protects against:</td>\n<td>CIN, Ca cervix</td>\n<td>Anogenital warts, CIN, Ca cervix</td>\n<td>Anogenital warts, CIN, CA cervix,  Vulval intraepithelial neoplasia, Vaginal intraepithelial neoplasia</td>\n</tr>\n<tr>\n<td>Dose</td>\n<td>0.5ml </td>\n<td>0.5ml</td>\n<td>0.5ml</td>\n</tr>\n<tr>\n<td>Administration</td>\n<td>0, 1, 6 months i.m</td>\n<td>0, 2, 6 months i.m</td>\n<td>0, 2, 6months, i.m</td>\n</tr>\n<tr>\n<td>Administered gender</td>\n<td>Female and male</td>\n<td>Female and male</td>\n<td>Female and male</td>\n</tr>\n<tr>\n<td>Ideal Age range:</td>\n<td>11-12 years,9-26 years </td>\n<td>11-12 years, 9-26 years for both male and female</td>\n<td>\n<p>Females:11-12 years, 9-26 years</p>\n<p>Males:11-12 years</p>\n<p>9-15 years - FDA approved</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Gardasil 9</strong> has received expanded indication, which now includes the <strong>prevention of oropharyngeal</strong> and other <strong>head and neck cancers</strong> caused by HPV types 16,18,31,33,45,52,58.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/5f392e1762c142ffb4f23324c1097a74.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0128",
      "difficulty": "medium"
    },
    {
      "text": "During a measles epidemic in the community, a 6-month-old child is brought to the vaccination camp. What would you do?",
      "choices": [
        {
          "id": 1,
          "text": "Proceed with the immunization of the child for measles"
        },
        {
          "id": 2,
          "text": "Give half of the dose of usual vaccination"
        },
        {
          "id": 3,
          "text": "No vaccination is given as the child is less than 9 months"
        },
        {
          "id": 4,
          "text": "Give the vaccine only if the child develops symptoms"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In the setting of a <strong>measles epidemic</strong>, we <strong>proceed with immunization</strong> of measles for this child.</p>\n<p>The scheduled age for receiving the <strong>first dose </strong>of measles vaccine is at <strong>9 months</strong>. The <strong>second dose </strong>is given between <strong>15 - 18 months </strong>of age such that the <strong>minimum interval </strong>between the 2 doses is <strong>4 weeks</strong>.&nbsp; A <strong>supplementary dose</strong> can be given at the age of <strong>&nbsp;6 months</strong> for the following cases:</p>\n<ul>\n<li><span>As a part of intensified service delivery during a <strong>measles outbreak&nbsp; </strong></span></li>\n<li><span>In places where the <strong>risk of measles</strong> among infants &lt; 9 months of age remains <strong>high</strong> (endemic countries experiencing regular outbreaks)</span></li>\n<li><span>Individual infants at high risk of contracting measles (<strong>history of contact</strong> with known cases)</span></li>\n<li><span>Infants <strong>traveling to countries</strong> experiencing measles outbreaks</span></li>\n<li><span>Infants who are known to be <strong>HIV-infected or exposed&nbsp;</strong></span></li>\n</ul>\n<p><span>Infants immunized between 6 months should further receive doses 1 and 2 according to the national schedule. Thus in the given case, this infant will be immunized at 6 months due to the epidemic and then receive the regular doses at 9 and 15-18 months of age.&nbsp;</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3597",
      "difficulty": "medium"
    },
    {
      "text": "Given below is a list of equipment used for the cold storage of vaccines.  Arrange the cold storage equipment in the correct order of usage, starting from the primary health center level to the national level.<div class='question-desc-html'><ol>\n<li>Walk-in-Freezers</li>\n<li>Walk-in-coolers</li>\n<li>Deep freezer</li>\n<li>Ice lined refrigerators</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "3-4-1-2"
        },
        {
          "id": 2,
          "text": "4-3-2-1"
        },
        {
          "id": 3,
          "text": "1-2-3-4"
        },
        {
          "id": 4,
          "text": "4-2-1-3"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The cold chain equipments that are used at various healthcare&nbsp;strata starting from the primary health center to the national level are <strong>4-3-2-1 </strong>i.e.<strong>&nbsp;ice lined refrigerators</strong>&nbsp;&rarr; <strong>deep freezer</strong>&nbsp;&rarr;&nbsp;<strong>walk-in-coolers</strong>&nbsp;&rarr;&nbsp;<strong>walk-in-freezers</strong>.</p>\n<p><strong>Ice-lined refrigerators&nbsp;(ILRs)&nbsp;</strong>are similar to conventional refrigerators and are lined with ice packs or tubes. They are categorized based on the vaccine storage capacity. Smaller ones are supplied to the<strong> primary health center</strong> (PHC) headquarters, while larger ones are supplied to district headquarters. They maintain a temperature of <strong>2-8&deg; Celsius</strong> for the storage of vaccines.&nbsp;They have different <strong>temperature zones </strong>for different vaccines and they are stored accordingly in the <strong>baskets</strong> that are provided in most ILRs.</p>\n<p><strong>Deep freezer (DF)</strong>&nbsp;is also similar to a conventional refrigerator but has a <strong>top-opening</strong> lid. It maintains a&nbsp;temperature of <strong>-15&deg; to -25&deg; celsius.&nbsp;</strong>It is used at the&nbsp;<strong>district level </strong>and above&nbsp;for the storage of oral polio vaccines for 3 months. At the&nbsp;<strong>sub-district level</strong>,&nbsp;it is used for freezing icepacks.</p>\n<p><strong>Walk-in-coolers (WIC)</strong>&nbsp;are insulated cold rooms with two cooling units with an uninterrupted power supply. They maintain a temperature of&nbsp;<strong>2-8&deg; celsius.&nbsp;</strong>They are used at government medical store depots,&nbsp;<strong>state, regional,</strong> and occasionally <strong>district</strong> level&nbsp;vaccine stores.&nbsp;</p>\n<p><strong>Walk-in-freezers (WIF)&nbsp;</strong>are similar to WIC but maintain a temperature of&nbsp;<strong>-15&deg; to -25&deg; celsius.&nbsp;</strong>They are used at <strong>national</strong>, state, and regional vaccine stores.</p><hr><h3>Related Pearl: Cold Chain Equipment</h3><p><strong>Cold chain equipment :&nbsp;</strong></p>\n<p><strong>Storage :&nbsp;</strong></p>\n<ul>\n<li>Walk in cooler (WIC)</li>\n<li>Walk in freezer (WIF)</li>\n<li>Ice lined refrigerator (ILR)</li>\n<li>Deep freezer&nbsp;</li>\n<li>Domestic refrigerator&nbsp;</li>\n</ul>\n<p>Solar :</p>\n<ul>\n<li>Solar Refrigerator Battery drive</li>\n<li>Solar Refrigerator Direct drive</li>\n</ul>\n<p>Non electrical :</p>\n<ul>\n<li>Cold box</li>\n<li>Vaccine carrier</li>\n</ul>\n<p><strong>Transportation :&nbsp;</strong></p>\n<ul>\n<li>Refrigerator vaccine van</li>\n<li>Insulated vaccine van</li>\n<li>Cold box&nbsp;</li>\n<li>Vaccine carrier</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/549c3f139636430fa5c659529a31d432x1280x1489.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Electrical Cold Chain Equipment:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Component</strong></p>\n</td>\n<td>\n<p><strong>Temperature (degree Celsius)</strong></p>\n</td>\n<td>\n<p><strong>Level</strong></p>\n</td>\n<td>\n<p><strong>Other Comments</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Walk in Freezers (WIF)</p>\n</td>\n<td>\n<p><strong>-15 to -25&nbsp; </strong></p>\n</td>\n<td>\n<p>National, State and Regional vaccine stores</p>\n</td>\n<td>\n<p>Used for bulk storage of <strong>OPV </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Walk in Coolers (WIC)</p>\n</td>\n<td>\n<p><strong>+2 to +8</strong></p>\n</td>\n<td>\n<p>Government Medical Store Depot (GMSD), State and Regional vaccines stores</p>\n</td>\n<td>\n<p>Used for bulk storage of most vaccines in UIP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Deep Freezer (DF)</p>\n</td>\n<td>\n<p><strong>-15 to -25&nbsp; </strong></p>\n</td>\n<td>\n<p>District and Sub-district vaccines stores</p>\n</td>\n<td>\n<p>Used for bulk storage of <strong>OPV</strong> and ice packs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ice Line Refrigerator (ILR)</p>\n</td>\n<td>\n<p><strong>+2 to +8</strong></p>\n</td>\n<td>\n<p>District and Sub-district vaccines stores, <strong>PHCs</strong></p>\n</td>\n<td>\n<p>Has different <strong>temperature zones </strong>for different vaccines</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Front Load Refrigerator (Domestic)</p>\n</td>\n<td>\n<p><strong>+2 to +8</strong></p>\n</td>\n<td>\n<p>Sub-district levels, hospitals. dispensaries and nursing homes</p>\n</td>\n<td>\n<p>Used for all vaccines</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Open Vial Policy</h3><p>Open vial policy allows for reuse of partially used <strong>multidose vials</strong> of applicable vaccines under the Universal Immunization Programme in subsequent sessions up to&nbsp;<strong>4&nbsp;weeks</strong> subject to certain conditions and thereby reducing vaccine wastage.</p>\n<p>It is applicable only for <strong>DPT, TT, hepatitis B vaccine, OPV, liquid pentavalent vaccine, rotavirus vaccine(new version with the VVM on the side), and JE vaccines (inactivated). </strong>It is not applicable to <strong>BCG and measles vaccines.&nbsp;</strong></p>\n<p>Vaccine vials opened in session-site can be used in more than one session up to four weeks if <strong>expiry date has not passed, if storage and transport was appropriate, no contamination has occurred in vial septum, asepsis in withdrawing was practiced and if vaccine vial monitor has not reached discard point.</strong></p>\n<p>Open vials should <strong>not</strong> be submerged in water. All open vials should have a record of&nbsp;<strong>date and time of opening</strong>. At the end of a session, all vaccines should be returned to the cold chain point and segregated as re-usable and non-reusable. All open vials of BCG, measles must be destroyed after 48 hours or before next session, whichever is earlier.</p>\n<p>In case of any <strong>adverse events following immunization</strong>, all open vials should not be discarded until investigation is complete. All vials must be transported in zipper bags in the vaccine carrier and recorded in stock register. Ice packs used should be well sealed.</p><hr><h3>Related Pearl: Vaccine Vial Monitors</h3><ul>\n<li><strong>Vaccine vial monitors</strong> are used to monitor heat exposure of vaccines.</li>\n<li>It is a chemical indicator that records the cumulative heat exposure through a gradual change in color.</li>\n<li>If the color of the <strong>inner square</strong> is the <strong>same color or darker</strong> than the <strong>outer circle</strong>, it indicates that the vaccine has been exposed to too much heat and it must be <strong>discarded</strong>.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3914a3eb19cf43ec9273112090e7b3f6x600x1199.JPEG\" alt=\"Pearl Image\"><ul>\n<li>Currently, there are <strong>four types</strong> of VVMs (VVM2, VVM7, VVM14, and VVM30). They are chosen to match the heat sensitivity of the vaccine.</li>\n<li>The VVM can be located on the label of the vaccine or on the neck or cap of the ampule/vial.</li>\n<li>VVMs also help in <strong>reduction of vaccine wastage</strong> by indicating which batch of vaccines can be used first.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1541",
      "difficulty": "medium"
    },
    {
      "text": "Identify the correct statement about the information obtained from the vaccine vial monitor 14 (VVM14) shown in the image below.",
      "choices": [
        {
          "id": 1,
          "text": "It takes 14 days for the inner square to become darker than outer circle"
        },
        {
          "id": 2,
          "text": "It takes 14 days for the inner square and outer circle to reach the same color"
        },
        {
          "id": 3,
          "text": "The vaccine can be used for 14 days after the inner square and outer circle reach the same color"
        },
        {
          "id": 4,
          "text": "The vaccine can be used for 14 days after the outer circle color  becomes darker"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div class=\"page\" title=\"Page 129\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The correct statement is option 2.</p>\n<p>The given scenario mentions<strong>&nbsp;VVM 14 </strong>(vaccine vial monitor 14), where <strong>14</strong> indicates the&nbsp;<strong>VVM number</strong>. It&nbsp;is the <strong>time in days</strong>&nbsp;for the <strong>inner square </strong>to reach the<strong> color of the outer circle </strong>when the vial is exposed to a constant temperature of 37&deg;C. This color change signifies the&nbsp;<strong>discard point</strong>&nbsp;of the vial.</p>\n</div>\n</div>\n</div>\n<p><strong>Vaccine Vial Monitors (VVM)</strong>&nbsp;are heat-sensitive indicators that are routinely used to monitor vaccine viability as the vaccine vial moves across the supply chain. It&nbsp;records&nbsp;<strong>cumulative heat exposure</strong>&nbsp;through a&nbsp;<strong>gradual change in color</strong>.</p>\n<p>There are currently 4 types of VVMs, they are chosen to match the <strong>heat sensitivity</strong> of the vaccines based on the VVM number.&nbsp;</p>\n<ul>\n<li>VVM 30: High Stability</li>\n<li>VVM 14: Medium Stability</li>\n<li>VVM 7: Moderate Stability</li>\n<li>VVM 2: Least Stable</li>\n</ul>\n<p>If the color of the<strong>&nbsp;inner square </strong>is the<strong> same </strong>or is<strong> darker than the outer</strong>&nbsp;circle, it indicates that the vaccine has been exposed to high temperatures and should be&nbsp;<strong>discarded.</strong></p>\n<p>Purpose of VVMs:</p>\n<ul>\n<li>Ensures that vaccines <strong>damaged by heat</strong> are not administered</li>\n<li>Decision on which vaccines to be kept after a <strong>cold chain break</strong> occurs, minimizing unnecessary vaccine wastage</li>\n<li>Decision on which <strong>vaccine</strong> is<strong> to be used first</strong>. Vaccines showing significant heat exposure should be used before those that show lower heat exposure, even if their expiry date is longer</li>\n</ul>\n<div class=\"page\" title=\"Page 129\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 129\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>There are two different locations for VVMs :</p>\n<ul>\n<li><strong>On the label</strong> of the vaccine: The vaccine vial, once opened, can be kept for subsequent immunization sessions for <strong>up to 28 days</strong>, regardless of the formulation of the product</li>\n<li>In a location <strong>other than on the label</strong> (e.g., cap or neck of ampoule): The vaccine vial, once opened should be discarded at the end of the immunization session or <strong>within six hours of opening</strong>, whichever comes first, regardless of the formulation of the product</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Vaccine Vial Monitors</h3><ul>\n<li><strong>Vaccine vial monitors</strong> are used to monitor heat exposure of vaccines.</li>\n<li>It is a chemical indicator that records the cumulative heat exposure through a gradual change in color.</li>\n<li>If the color of the <strong>inner square</strong> is the <strong>same color or darker</strong> than the <strong>outer circle</strong>, it indicates that the vaccine has been exposed to too much heat and it must be <strong>discarded</strong>.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3914a3eb19cf43ec9273112090e7b3f6x600x1199.JPEG\" alt=\"Pearl Image\"><ul>\n<li>Currently, there are <strong>four types</strong> of VVMs (VVM2, VVM7, VVM14, and VVM30). They are chosen to match the heat sensitivity of the vaccine.</li>\n<li>The VVM can be located on the label of the vaccine or on the neck or cap of the ampule/vial.</li>\n<li>VVMs also help in <strong>reduction of vaccine wastage</strong> by indicating which batch of vaccines can be used first.</li>\n</ul><hr><h3>Related Pearl: Temperature Sensitivity of Vaccines</h3><p><strong>Heat sensitivity</strong> in order of <strong>decreasing</strong> sensitivity:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>Group</td>\n<td>Vaccines</td>\n</tr>\n<tr>\n<td>A</td>\n<td>OPV</td>\n</tr>\n<tr>\n<td>B</td>\n<td>Influenza</td>\n</tr>\n<tr>\n<td>C</td>\n<td>\n<p>IPV</p>\n<p>Japanese encephalitis(live)</p>\n<p>Measles, mumps, rubella</p>\n</td>\n</tr>\n<tr>\n<td>D</td>\n<td>\n<p>Cholera</p>\n<p>DTaP</p>\n<p>Pentavalent</p>\n<p>Rotavirus</p>\n<p>Hib(liquid)</p>\n<p>Yellow fever</p>\n<p>Measles</p>\n<p>Rubella</p>\n</td>\n</tr>\n<tr>\n<td>E</td>\n<td>\n<p>BCG</p>\n<p>HPV</p>\n<p>Japanese encephalitis(inactivated)</p>\n<p>Tetanus, TD, Td</p>\n</td>\n</tr>\n<tr>\n<td>F</td>\n<td>\n<p>Hepatitis B</p>\n<p>Hib(freeze-dried)</p>\n<p>Meningococcal A</p>\n<p>Pneumococcal</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Vaccine <strong>sensitivity to freezing</strong>:</p>\n<p><strong>Rotavirus(liquid)</strong>&lt; T,DT,dT&lt; IPV &lt; Hib(liquid)&lt; HepB &lt; Pentavalent &lt;<strong>DTaP</strong></p>\n<p>Vaccines not damaged by freezing:</p>\n<ul>\n<li>Yellow fever</li>\n<li>BCG</li>\n<li>Hib</li>\n<li>Japanese encephalitis(live and inactivated)</li>\n<li>Measles, mumps, rubella</li>\n<li>OPV</li>\n<li>Rabies</li>\n<li>Rotavirus(Freeze-dried)</li>\n<li>Varicella zoster</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c7bd80ca927b42bcb0956bc12ae146b7x956x717.PNG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Cold Chain Equipment</h3><p><strong>Cold chain equipment :&nbsp;</strong></p>\n<p><strong>Storage :&nbsp;</strong></p>\n<ul>\n<li>Walk in cooler (WIC)</li>\n<li>Walk in freezer (WIF)</li>\n<li>Ice lined refrigerator (ILR)</li>\n<li>Deep freezer&nbsp;</li>\n<li>Domestic refrigerator&nbsp;</li>\n</ul>\n<p>Solar :</p>\n<ul>\n<li>Solar Refrigerator Battery drive</li>\n<li>Solar Refrigerator Direct drive</li>\n</ul>\n<p>Non electrical :</p>\n<ul>\n<li>Cold box</li>\n<li>Vaccine carrier</li>\n</ul>\n<p><strong>Transportation :&nbsp;</strong></p>\n<ul>\n<li>Refrigerator vaccine van</li>\n<li>Insulated vaccine van</li>\n<li>Cold box&nbsp;</li>\n<li>Vaccine carrier</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/549c3f139636430fa5c659529a31d432x1280x1489.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Electrical Cold Chain Equipment:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Component</strong></p>\n</td>\n<td>\n<p><strong>Temperature (degree Celsius)</strong></p>\n</td>\n<td>\n<p><strong>Level</strong></p>\n</td>\n<td>\n<p><strong>Other Comments</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Walk in Freezers (WIF)</p>\n</td>\n<td>\n<p><strong>-15 to -25&nbsp; </strong></p>\n</td>\n<td>\n<p>National, State and Regional vaccine stores</p>\n</td>\n<td>\n<p>Used for bulk storage of <strong>OPV </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Walk in Coolers (WIC)</p>\n</td>\n<td>\n<p><strong>+2 to +8</strong></p>\n</td>\n<td>\n<p>Government Medical Store Depot (GMSD), State and Regional vaccines stores</p>\n</td>\n<td>\n<p>Used for bulk storage of most vaccines in UIP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Deep Freezer (DF)</p>\n</td>\n<td>\n<p><strong>-15 to -25&nbsp; </strong></p>\n</td>\n<td>\n<p>District and Sub-district vaccines stores</p>\n</td>\n<td>\n<p>Used for bulk storage of <strong>OPV</strong> and ice packs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ice Line Refrigerator (ILR)</p>\n</td>\n<td>\n<p><strong>+2 to +8</strong></p>\n</td>\n<td>\n<p>District and Sub-district vaccines stores, <strong>PHCs</strong></p>\n</td>\n<td>\n<p>Has different <strong>temperature zones </strong>for different vaccines</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Front Load Refrigerator (Domestic)</p>\n</td>\n<td>\n<p><strong>+2 to +8</strong></p>\n</td>\n<td>\n<p>Sub-district levels, hospitals. dispensaries and nursing homes</p>\n</td>\n<td>\n<p>Used for all vaccines</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/379a129517164991916eee55809230e8.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9455",
      "difficulty": "medium"
    },
    {
      "text": "A 7-week-old child presented with abdominal pain and red currant jelly stools. The mother gives a history of vaccination to the child 1 week prior. A barium enema is done, and the image is given below. Which of the following vaccine is likely to be responsible for this adverse effect?",
      "choices": [
        {
          "id": 1,
          "text": "Rotavirus vaccine"
        },
        {
          "id": 2,
          "text": "Pentavalent vaccine"
        },
        {
          "id": 3,
          "text": "Pneumococcal conjugate vaccine"
        },
        {
          "id": 4,
          "text": "Oral Polio vaccine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p>The clinical scenario of<strong> abdominal pain, red currant jelly stool </strong>along with barium enema showing the <strong>claw sign</strong> is suggestive of <strong>intussusception. </strong>The mother gives a history of vaccination at 6 weeks of age and the <strong>Rotavirus vaccine</strong> is associated with a risk of developing <strong>intussusception, </strong>usually <strong>within a week</strong> <strong>after the first or second dose.</strong></p>\n<p>Intussusception occurs when a portion of the bowel is<strong> telescoped</strong> into an adjacent segment.<strong> </strong>It can be seen in infants during the weaning period following the introduction of new food, vaccination, or upper respiratory tract infection. The currently approved <strong>rotavirus vaccines</strong> are associated with a very minimal risk of intussusception. An area of enlarged submucosal <strong>Peyer's patch</strong> acts as a lead point for intussusception.</p>\n<p>Some <strong>lead points</strong> in children are <strong>Meckel's diverticulum,</strong> intestinal polyp, inflamed appendix, submucosal hemorrhage seen in <strong>Henoch-Schonlein purpura</strong>, and intestinal duplication cysts. Patients present with <strong>cramping abdominal pain</strong>, palpable <strong>sausage-shaped abdominal mass</strong>, vomiting, and passage of <strong>red currant jelly stools</strong>. <strong>Diagnosis</strong> is confirmed by <strong>abdominal ultrasound </strong>which shows<strong> the t</strong><strong>arget sign/bull's eye sign </strong>(shown below)<strong> </strong>and<strong> pseudo kidney</strong><strong> sign</strong> (seen longitudinally).</p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d81d8af7dc2c42c1847e0212ef827ddfx720x598.JPEG\" alt=\"Explanation Image\"><div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p>Barium enema shows a typical <strong>claw sign</strong> (shown below). This<strong> </strong>appearance is due to the barium in the lumen of the intussusceptum and in the intraluminal space<strong>.</strong></p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/322a6381b6a84dfd93a2fda7c2454257x1144x1136.PNG\" alt=\"Explanation Image\"><p>Treatment of intussusception includes <strong>hydrostatic reduction</strong> by enema using contrast material or air. <strong>S</strong><strong>urgical</strong> reduction is only done in the presence of refractory <strong>shock,</strong> suspected bowel necrosis or <strong>perforation,</strong> <strong>peritonitis,</strong> and multiple recurrences after hydrostatic reduction. </p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c903dc979355418eaf9fb3b833293406.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8682",
      "difficulty": "easy"
    },
    {
      "text": "Open vial policy is applicable for which of the following vaccines?<div class='question-desc-html'><ol>\n<li>BCG</li>\n<li>DPT vaccine</li>\n<li>Oral Polio vaccine</li>\n<li>MR vaccine</li>\n<li>Pneumococcal conjugate vaccine</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2,3,5"
        },
        {
          "id": 2,
          "text": "1,4"
        },
        {
          "id": 3,
          "text": "1,3,4"
        },
        {
          "id": 4,
          "text": "2,3,4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Among the given vaccines open vial policy is applicable for the <strong>DPT vaccine, Oral Polio vaccine, and Pneumococcal conjugate vaccine</strong>.</p>\n<p>Open vial policy <strong>applies</strong> to <strong>DPT, TT, Hepatitis B, Oral Polio Vaccine (OPV), Liquid Pentavalent, PCV, and injectable IPV.</strong><br />It does <strong>not</strong> <strong>apply</strong> to <strong>Measles/MR, BCG, or Japanese Encephalitis (JE) vaccines.</strong><br /><br />Vaccine vials opened in session-site can be used in more than one immunization session for up to<strong> four weeks</strong> provided</p>\n<ul>\n<li>The expiry date has not passed.</li>\n<li>Vaccines are stored strictly under an appropriate temperature range both during transportation &amp; storage at cold chain points.</li>\n<li>The vaccine vial septum has not been submerged in water or contaminated in any way.</li>\n<li>An aseptic technique has been used to withdraw all doses.</li>\n<li>The vaccine vial monitor (VVM), has not reached the discard point.</li>\n</ul>\n<p>Ensure all open vials have recorded the date and time of opening. All vials (open or unopened) should be transported in a zipper bag in the vaccine carrier and recorded in the stock register. Well-sealed conditioned ice packs should be used in vaccine carriers and water should not be allowed to accumulate where vaccine vials and diluents are stored.</p><hr><h3>Related Pearl: National Immunization Schedule (India)</h3><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>When to give</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Route</strong></td>\n<td><strong>Site</strong></td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Pregnant Women</strong></td>\n</tr>\n<tr>\n<td>Td-1</td>\n<td>\n<p>Early in pregnancy</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-2</td>\n<td>\n<p>4 weeks after Td-1*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td- Booster</td>\n<td>\n<p>If received 2 Td doses in a pregnancy <br />within the last 3 yrs*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Infants</strong></td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>At birth or as early as possible until one year of age</p>\n</td>\n<td>0.1 mL (0.05 mL until<br />1 month<br />age)</td>\n<td>Intra-dermal</td>\n<td>Left upper arm</td>\n</tr>\n<tr>\n<td>Hepatitis B - Birth Dose</td>\n<td>\n<p>At birth or as early as possible within 24 hrs</p>\n</td>\n<td>0.5 mL</td>\n<td> Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>OPV - 0</td>\n<td>\n<p>At birth or as early as possible within the first 15 days</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>OPV-1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until 5 years of age)</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>Pentavalent 1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>0.5 mL</td>\n<td>lntra·muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>Rotavirus</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>5 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>IPV</td>\n<td>\n<p>Two fractional doses at 6, 14 weeks </p>\n</td>\n<td>0.1 mL</td>\n<td>Intra-dermal two fractional dose</td>\n<td>Intra-dermal: right Upper arm (at 6, 14 weeks)<br /><br /></td>\n</tr>\n<tr>\n<td>\n<p>PCV</p>\n<p>(wherever applicable)</p>\n</td>\n<td>\n<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra·muscular</td>\n<td>Antero-lateral side of mid-thigh, right</td>\n</tr>\n<tr>\n<td>Measles/MR 1<sup>st</sup> Dose</td>\n<td>\n<p>9 completed months to 12 months<br />(Can be given till 5 years of age)</p>\n</td>\n<td>0.5ml</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm</td>\n</tr>\n<tr>\n<td>JE- 1**</td>\n<td>\n<p>9 completed months to 12 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular(killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>\n<p>Anterolateral aspect of mid-thigh/Left upper arm </p>\n</td>\n</tr>\n<tr>\n<td>Vitamin A<br />(1st dose)</td>\n<td>\n<p>At 9 completed months with measles Rubella</p>\n</td>\n<td>1 mL (1 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Children </strong></td>\n</tr>\n<tr>\n<td>DPT booster-1</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh  </td>\n</tr>\n<tr>\n<td>Measles / MR 2<sup>nd </sup>dose</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm  </td>\n</tr>\n<tr>\n<td>OPV booster</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>JE-2</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular (killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>Anterolateral aspect of mid-thigh/Left upper arm </td>\n</tr>\n<tr>\n<td>Vitamin A***<br />(2nd to 9<sup>th</sup> dose)</td>\n<td>\n<p>16–18 months, followed by one dose every 6 months up to the age of 5 years</p>\n</td>\n<td>2 mL (2 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>DPT booster 2</td>\n<td>\n<p>5–6 years</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td</td>\n<td>10 years &amp; 16 years</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>\n<p>Upper arm</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>\n<p>**JE vaccine is introduced in select endemic districts after the campaigns. Intramuscular (killed inactivated) vaccine is gradually replacing the live attenuated vaccine. This change is because the killed vaccines are more effective and require fewer doses.</p>\n<p>***The 2nd to 9th doses of vitamin A can be administered to children 1–5 years old during biannual rounds, in collaboration with ICDS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8663",
      "difficulty": "medium"
    },
    {
      "text": "A baby is brought to the pediatrician for the general assessment. During the examination, it is observed that the baby can stand holding support. On giving a small pebble to the baby, the baby tries to hold it between the index and the thumb finger. She also waves bye-bye and can say mama. Which of the following vaccines can be given to this baby if the development is appropriate for her age and if she has not missed any prior immunization?",
      "choices": [
        {
          "id": 1,
          "text": "Oral polio vaccine-3, Pentavalent 2, rotavirus-2"
        },
        {
          "id": 2,
          "text": "Oral polio vaccine-3, Pentavalent 3, rotavirus-2"
        },
        {
          "id": 3,
          "text": "Measles and Rubella-1, Japanese encephalitis vaccine, Pneumococcal conjugate vaccine booster, Vitamin A 1 lakh IU"
        },
        {
          "id": 4,
          "text": "Measles and Rubella-1, Pneumococcal conjugate vaccine booster, Vitmain A 2 Lakhs IU"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>According to the developmental assessment, the child has attained <strong>9 months</strong> of age.</p>\n<p><strong>A 9-month-old baby&nbsp;</strong>can <strong>stand with support;&nbsp;</strong>has a&nbsp;<strong>pincer grasp;&nbsp;</strong>waves <strong>bye-bye;&nbsp;</strong>and can say bisyllabic words like<strong> mama, baba, dada.&nbsp;</strong></p>\n<p>Vaccines given at this age:</p>\n<ul>\n<li><strong>Measles and rubella vaccine (MR-1)</strong> -1st dose of measles and rubella</li>\n<li><strong>Japanese encephalitis vaccine(JE-1)</strong>:1st dose(In <strong>endemic districts</strong>)</li>\n<li><strong>Vitamin A</strong>- 1st dose with<strong> 1 lakh</strong> IU</li>\n<li>Children who are staying in Bihar, Himachal Pradesh, Madhya Pradesh, Uttar Pradesh, Rajasthan, and Haryana should be additionally given a booster dose of <strong>pneumococcal conjugate vaccine (PCV)</strong>.</li>\n</ul>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>National immunisation schedule</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Birth</td>\n<td>\n<p>Bacille Calmette-Guerin (BCG)</p>\n<p>Oral polio vaccine (OPV)-0 dose</p>\n<p>Hepatitis B- Birth dose</p>\n</td>\n</tr>\n<tr>\n<td>6 weeks</td>\n<td>\n<p>OPV- 1</p>\n<p>Pentavalent- 1</p>\n<p>Rotavirus vaccine (RVV)-1</p>\n<p>Inactivated Polio vaccine (IPV) -1</p>\n<p>Pneumococcal conjugate vaccine (PCV)-1</p>\n</td>\n</tr>\n<tr>\n<td>10 weeks</td>\n<td>\n<p>OPV2</p>\n<p>Pentavalent- 2</p>\n<p>RVV- 2</p>\n</td>\n</tr>\n<tr>\n<td>14 weeks</td>\n<td>\n<p>OPV-3</p>\n<p>Pentavalent- 3</p>\n<p>IPV- 2</p>\n<p>RVV- 3</p>\n<p>PCV- 2</p>\n</td>\n</tr>\n<tr>\n<td>9-12 months</td>\n<td>\n<p>Measles and Rubella (MR)-1</p>\n<p>IPV-3</p>\n<p>Japanese encepahlitis- (JE)- 1</p>\n<p>PCV booster</p>\n<p>Vitamin A 1 lakh IU</p>\n</td>\n</tr>\n<tr>\n<td>16-24 months</td>\n<td>\n<p>MR- 2</p>\n<p>JE- 2</p>\n<p>Diphtheria, tetanus, pertussis (DPT) booster - 1</p>\n<p>OPV booster</p>\n</td>\n</tr>\n<tr>\n<td>5-6 years&nbsp;</td>\n<td>DPT booster-2</td>\n</tr>\n<tr>\n<td>10 years</td>\n<td>Tetanus and adult Diphtheria (Td)</td>\n</tr>\n<tr>\n<td>16 years&nbsp;</td>\n<td>Td</td>\n</tr>\n<tr>\n<td>Pregnant mother</td>\n<td>Td 1, Td 2, or Td booster</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Pneumococcal conjugate vaccine</strong> and <strong>Japanese encephalitis vaccine</strong> are given <strong>only</strong> in the <strong>endemic</strong> areas.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Gross motor milestones</h3><table><caption>&nbsp;</caption>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Milestone</strong></td>\n</tr>\n<tr>\n<td>3 months</td>\n<td>Neck holding</td>\n</tr>\n<tr>\n<td>5 months</td>\n<td>Rolls over</td>\n</tr>\n<tr>\n<td>6 months</td>\n<td>Sits with support</td>\n</tr>\n<tr>\n<td>8 months</td>\n<td>Sits without support</td>\n</tr>\n<tr>\n<td>9 months</td>\n<td>Stands with support</td>\n</tr>\n<tr>\n<td>12 months</td>\n<td>\n<p>Stands without support</p>\n<p>Creeps well</p>\n<p>Walks but falls</p>\n</td>\n</tr>\n<tr>\n<td>15 months</td>\n<td>\n<p>Walks without support</p>\n<p>Creeps upstairs</p>\n</td>\n</tr>\n<tr>\n<td>18 months</td>\n<td>Runs</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>Walks upstairs and downstairs (2 feet/step)</td>\n</tr>\n<tr>\n<td>3 years</td>\n<td>\n<p>Walks upstairs with alternate foot</p>\n<p>Rides tricycle</p>\n</td>\n</tr>\n<tr>\n<td>4 years</td>\n<td>\n<p>Walks downstairs with alternate foot</p>\n<p>Hopping on 1 foot</p>\n</td>\n</tr>\n<tr>\n<td>5 years</td>\n<td>Can skip without falling to either side</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Language milestones</h3><div>\n<table><caption>&nbsp;</caption>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Milestone</strong></td>\n</tr>\n<tr>\n<td>1 month</td>\n<td>Alerts to sound</td>\n</tr>\n<tr>\n<td>2 months</td>\n<td>Coos (musical vowel sound)</td>\n</tr>\n<tr>\n<td>4 months</td>\n<td>Laughs aloud</td>\n</tr>\n<tr>\n<td>6 months</td>\n<td>Monosyllables sounds (ma, ba)</td>\n</tr>\n<tr>\n<td>9 months</td>\n<td>Bisyllables (mama, baba)</td>\n</tr>\n<tr>\n<td>12 months</td>\n<td>1-2 words with meaning</td>\n</tr>\n<tr>\n<td>18 months</td>\n<td>8-10 word vocabulary</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>2-3 word sentences (uses pronouns like I, me, you)</td>\n</tr>\n<tr>\n<td>3 years</td>\n<td>Asks questions and knows name and gender</td>\n</tr>\n<tr>\n<td>4 years</td>\n<td>Sings songs, poems and tells stories</td>\n</tr>\n<tr>\n<td>5 years</td>\n<td>Asks meaning of words</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div><hr><h3>Related Pearl: Fine motor milestones</h3><table><caption>&nbsp;</caption>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Milestone</strong></td>\n</tr>\n<tr>\n<td>4 months</td>\n<td>Reaches out for objects with both hands (Bidextrous reach)</td>\n</tr>\n<tr>\n<td>\n<div>6 months</div>\n</td>\n<td>\n<div>Reaches out for objects with one hand (Unidextrous reach) and transfers objects</div>\n</td>\n</tr>\n<tr>\n<td>9 months</td>\n<td>Immature pincer grasp</td>\n</tr>\n<tr>\n<td>12 months</td>\n<td>Mature pincer grasp</td>\n</tr>\n<tr>\n<td>15 months</td>\n<td>Imitates scribbling and builds a tower of 2 blocks</td>\n</tr>\n<tr>\n<td>18 months</td>\n<td>Scribbles and builds a tower of 3 blocks</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>Builds a tower of 6 blocks</td>\n</tr>\n<tr>\n<td>3 years</td>\n<td>Builds a tower of 9 blocks and copies a circle</td>\n</tr>\n<tr>\n<td>4 years</td>\n<td>Builds a bridge with blocks and copies a cross</td>\n</tr>\n<tr>\n<td>5 years</td>\n<td>Copies a triangle and&nbsp;builds a gate with blocks</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4773a150d41047a29789e417bb2993e1x1280x936.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9197",
      "difficulty": "easy"
    },
    {
      "text": "A 24-year-old pregnant woman comes to you in her first trimester and asks for your advice regarding immunisation. Which of the following vaccines would you tell is contraindicated for her?",
      "choices": [
        {
          "id": 1,
          "text": "Hepatitis A vaccine"
        },
        {
          "id": 2,
          "text": "Hepatitis B vaccine"
        },
        {
          "id": 3,
          "text": "Tetanus toxoid"
        },
        {
          "id": 4,
          "text": "Varicella vaccine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Varicella vaccine</strong> is <strong>contraindicated</strong>&nbsp;for her as she is <strong>pregnant</strong>.</p>\n<p>Varicella vaccine is a<strong> live attenuated</strong> vaccine which is recommended for <strong>children</strong> aged <strong>12-18 months</strong> and those without a history of chickenpox infection in the past. It is administered <strong>subcutaneously</strong> in one or two-dose schedules.&nbsp;</p>\n<p>It is contraindicated in <strong>pregnant</strong>,&nbsp;<strong>immunocompromised</strong> individuals and those who are <strong>allergic</strong> to <strong>neomycin</strong>. However, patients with clinically stable HIV on HAART (highly active anti-retroviral therapy) can be considered for vaccination if CD4+ cells &gt;15%. Avoidance of <strong>salicylates</strong> is recommended<strong> 6 weeks</strong> after the vaccination to prevent <strong>Reye's syndrome</strong>.&nbsp;</p>\n<p>Maternal varicella infection may result in<strong> fetal loss</strong> and<strong> birth defects</strong>. If maternal varicella infection occurs within <strong>5 days</strong> of <strong>delivery</strong>, the baby should receive <strong>VZIG </strong>(varicella-zoster immunoglobulin) due to the risk of disseminated infection.</p>\n<p>Other options:&nbsp;</p>\n<p>Options A: <strong>Hepatitis A vaccine&nbsp;</strong>can be administered as pre-exposure or post-exposure prophylaxis in <strong>high-risk pregnant</strong> individuals in a two-dose schedule given <strong>intramuscularly</strong> one month apart.</p>\n<p>Option B:&nbsp;<strong>Hepatitis B</strong>&nbsp;<strong>vaccine</strong> can be administered as pre-exposure or post-exposure prophylaxis in <strong>high-risk pregnant</strong> individuals. It is given <strong>intramuscularly</strong> in three doses at 0, 1, and 6 months.&nbsp;</p>\n<p>Option C:&nbsp;<strong>Tetanus toxoid</strong> is routinely administered in pregnant women. The <strong>first dose</strong> is given at <strong>16-20 weeks</strong> while the <strong>second dose</strong> is at <strong>20-24</strong> <strong>weeks</strong> ideally maintaining a one-month interval between the two doses.</p><hr><h3>Related Pearl: Types of Vaccines</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type</strong></p>\n</td>\n<td>\n<p><strong>Vaccines</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Live attenuated</p>\n<p>(<strong>M</strong>ost<strong>&nbsp;</strong><strong>B</strong>eautiful&nbsp;<strong>P</strong>lace&nbsp;<strong>I</strong>n&nbsp;<strong>T</strong>he <strong>W</strong>orld<strong>&nbsp;</strong>-<strong> ROME)</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><strong>M</strong>umps</p>\n<p><strong>B</strong>CG</p>\n<p><strong>P</strong>lague</p>\n<p><strong>I</strong>nfluenza (cold-adapted)</p>\n<p><strong>T</strong>yphoid (oral)</p>\n<p>Yello<strong>W&nbsp;</strong>fever</p>\n<p><strong>R</strong>ubella and&nbsp;<strong>R</strong>otavirus</p>\n<p><strong>O</strong>ral Polio (Sabin)</p>\n<p><strong>M</strong>easles</p>\n<p>Japanese&nbsp;<strong>E</strong>ncephalitis</p>\n<p>Varicella</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Killed whole organism</p>\n<p>(<strong>RIP</strong> <strong>ACE</strong>)</p>\n</td>\n<td>\n<p><strong>R</strong>abies</p>\n<p><strong>I</strong>nfluenza</p>\n<p><strong>P</strong>olio (IPV, Salk)</p>\n<p>Hep <strong>A</strong></p>\n<p><strong>C</strong>holera</p>\n<p><strong>E</strong>ncephalitis</p>\n<p>Typhoid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Toxoid/Protein</p>\n</td>\n<td>\n<p>Diphtheria</p>\n<p>Tetanus</p>\n<p>Acellular Pertussis</p>\n<p>Anthrax</p>\n<p>Influenza subunit&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Polysaccharide</p>\n</td>\n<td>\n<p>Pneumococcus</p>\n<p>Meningococcus</p>\n<p>Hemophilus influenza type b (Hib)</p>\n<p>Typhoid (Vi)&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>Glycoconjugate</p>\n</td>\n<td>\n<p>Hib</p>\n<p>Pneumococcus</p>\n<p>MenACWY(meningococcal vaccine)&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Recombinant</p>\n</td>\n<td>\n<p>Hepatitis B vaccine</p>\n<p>Lyme disease</p>\n<p>Cholera toxin B</p>\n<p>HPV&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Contraindications to Vaccines</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vaccine</strong></p>\n</td>\n<td>\n<p><strong>Contraindications</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>All</p>\n</td>\n<td>\n<p>Anaphylactic reaction to previous dose</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Live vaccines (MMR, BCG, Varicella)</p>\n</td>\n<td>\n<p>Pregnancy</p>\n<p>Radiation therapy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Yellow fever</p>\n</td>\n<td>\n<p>Egg allergy</p>\n<p>Immunodeficiency</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>BCG</p>\n</td>\n<td>\n<p>Symptomatic HIV infection</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Influenza</p>\n</td>\n<td>\n<p>Egg allergy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pertussis-containing vaccines</p>\n</td>\n<td>\n<p>Evolving neurological disorders</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8083",
      "difficulty": "easy"
    },
    {
      "text": "Where is the DPT vaccine stored in an ice-lined refrigerator(ILR)?",
      "choices": [
        {
          "id": 1,
          "text": "Stored in the lower zone as it is freeze sensitive"
        },
        {
          "id": 2,
          "text": "Stored in the upper zone as it is freeze sensitive"
        },
        {
          "id": 3,
          "text": "Stored in the upper zone as it is heat sensitive"
        },
        {
          "id": 4,
          "text": "Stored in the lower zone as it is heat sensitive"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>DPT vaccine is <strong>freeze sensitive</strong> and hence stored in the <strong>upper zone</strong> of an ice-lined refrigerator(ILR).</p>\n<p><strong>Freeze sensitive vaccines</strong></p>\n<ul>\n<li>Cholera</li>\n<li>DTaP-hepatitis B-Hib-IPV (hexavalent)</li>\n<li>DIwP or DTwP-hepatitis B-Hib (pentavalent) Hepatitis B (Hep B)</li>\n<li>Hib (liquid)</li>\n<li>Human papillomavirus (HPV)</li>\n<li>Inactivated poliovirus (IPV)</li>\n<li>Influenza</li>\n<li>Pneumococcal</li>\n<li>Tetanus, DT, Td</li>\n<li>Rotavirus (liquid and freeze-dried)</li>\n</ul>\n<p><strong>Ice-lined refrigerators</strong> (ILRs) are the main method of vaccine storage in <strong>primary health centers </strong>(PHCs).ILRs are an important part of the cold chain and they maintain a temperature of <strong>2 to 8 degree Celsius</strong> for storage of vaccines. They have different <strong>temperature zones </strong>for different vaccines and they are stored accordingly in the <strong>baskets</strong> that are provided in most ILRs.The ILRs are lined ice packs or tubes. <strong>Dial</strong> or digital thermometers are used to record temperatures inside an ILR. The below <strong>image</strong> shows an<strong> Ice-lined Refrigerator</strong> (ILR).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bbf200ea2a5f43cfa9a8942fbb3c643ex1279x1264.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Cold Chain Equipment</h3><p><strong>Cold chain equipment :&nbsp;</strong></p>\n<p><strong>Storage :&nbsp;</strong></p>\n<ul>\n<li>Walk in cooler (WIC)</li>\n<li>Walk in freezer (WIF)</li>\n<li>Ice lined refrigerator (ILR)</li>\n<li>Deep freezer&nbsp;</li>\n<li>Domestic refrigerator&nbsp;</li>\n</ul>\n<p>Solar :</p>\n<ul>\n<li>Solar Refrigerator Battery drive</li>\n<li>Solar Refrigerator Direct drive</li>\n</ul>\n<p>Non electrical :</p>\n<ul>\n<li>Cold box</li>\n<li>Vaccine carrier</li>\n</ul>\n<p><strong>Transportation :&nbsp;</strong></p>\n<ul>\n<li>Refrigerator vaccine van</li>\n<li>Insulated vaccine van</li>\n<li>Cold box&nbsp;</li>\n<li>Vaccine carrier</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/549c3f139636430fa5c659529a31d432x1280x1489.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Electrical Cold Chain Equipment:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Component</strong></p>\n</td>\n<td>\n<p><strong>Temperature (degree Celsius)</strong></p>\n</td>\n<td>\n<p><strong>Level</strong></p>\n</td>\n<td>\n<p><strong>Other Comments</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Walk in Freezers (WIF)</p>\n</td>\n<td>\n<p><strong>-15 to -25&nbsp; </strong></p>\n</td>\n<td>\n<p>National, State and Regional vaccine stores</p>\n</td>\n<td>\n<p>Used for bulk storage of <strong>OPV </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Walk in Coolers (WIC)</p>\n</td>\n<td>\n<p><strong>+2 to +8</strong></p>\n</td>\n<td>\n<p>Government Medical Store Depot (GMSD), State and Regional vaccines stores</p>\n</td>\n<td>\n<p>Used for bulk storage of most vaccines in UIP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Deep Freezer (DF)</p>\n</td>\n<td>\n<p><strong>-15 to -25&nbsp; </strong></p>\n</td>\n<td>\n<p>District and Sub-district vaccines stores</p>\n</td>\n<td>\n<p>Used for bulk storage of <strong>OPV</strong> and ice packs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ice Line Refrigerator (ILR)</p>\n</td>\n<td>\n<p><strong>+2 to +8</strong></p>\n</td>\n<td>\n<p>District and Sub-district vaccines stores, <strong>PHCs</strong></p>\n</td>\n<td>\n<p>Has different <strong>temperature zones </strong>for different vaccines</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Front Load Refrigerator (Domestic)</p>\n</td>\n<td>\n<p><strong>+2 to +8</strong></p>\n</td>\n<td>\n<p>Sub-district levels, hospitals. dispensaries and nursing homes</p>\n</td>\n<td>\n<p>Used for all vaccines</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Temperature Sensitivity of Vaccines</h3><p><strong>Heat sensitivity</strong> in order of <strong>decreasing</strong> sensitivity:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>Group</td>\n<td>Vaccines</td>\n</tr>\n<tr>\n<td>A</td>\n<td>OPV</td>\n</tr>\n<tr>\n<td>B</td>\n<td>Influenza</td>\n</tr>\n<tr>\n<td>C</td>\n<td>\n<p>IPV</p>\n<p>Japanese encephalitis(live)</p>\n<p>Measles, mumps, rubella</p>\n</td>\n</tr>\n<tr>\n<td>D</td>\n<td>\n<p>Cholera</p>\n<p>DTaP</p>\n<p>Pentavalent</p>\n<p>Rotavirus</p>\n<p>Hib(liquid)</p>\n<p>Yellow fever</p>\n<p>Measles</p>\n<p>Rubella</p>\n</td>\n</tr>\n<tr>\n<td>E</td>\n<td>\n<p>BCG</p>\n<p>HPV</p>\n<p>Japanese encephalitis(inactivated)</p>\n<p>Tetanus, TD, Td</p>\n</td>\n</tr>\n<tr>\n<td>F</td>\n<td>\n<p>Hepatitis B</p>\n<p>Hib(freeze-dried)</p>\n<p>Meningococcal A</p>\n<p>Pneumococcal</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Vaccine <strong>sensitivity to freezing</strong>:</p>\n<p><strong>Rotavirus(liquid)</strong>&lt; T,DT,dT&lt; IPV &lt; Hib(liquid)&lt; HepB &lt; Pentavalent &lt;<strong>DTaP</strong></p>\n<p>Vaccines not damaged by freezing:</p>\n<ul>\n<li>Yellow fever</li>\n<li>BCG</li>\n<li>Hib</li>\n<li>Japanese encephalitis(live and inactivated)</li>\n<li>Measles, mumps, rubella</li>\n<li>OPV</li>\n<li>Rabies</li>\n<li>Rotavirus(Freeze-dried)</li>\n<li>Varicella zoster</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c7bd80ca927b42bcb0956bc12ae146b7x956x717.PNG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8701",
      "difficulty": "medium"
    },
    {
      "text": "What is the schedule for pre-exposure prophylaxis in rabies vaccination?",
      "choices": [
        {
          "id": 1,
          "text": "0, 3, 7, 14, 28"
        },
        {
          "id": 2,
          "text": "0, 3, 28"
        },
        {
          "id": 3,
          "text": "0, 14, 28"
        },
        {
          "id": 4,
          "text": "0, 7, and 21 or 28"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Pre-exposure prophylaxis is given on days <strong>0, 7, and 21 or 28</strong>.</p>\n<p>Pre-exposure prophylaxis can be administered via the <strong>intramuscular route</strong> with a dose of 1ml or 0.5 ml, depending on the vaccine type, or <strong>intradermal route</strong> of 0.1 ml volume per site (one site each day) given on days 0, 7, and 21 or 28.&nbsp;</p>\n<p>PrEP is recommended for anyone who is at continual, frequent, or <strong>increased risk of exposure</strong> to the rabies virus either as a result of their residence or occupation laboratory workers dealing with the rabies virus and other lyssa viruses, veterinarians, and animal handlers). For people who are potentially at risk of <strong>laboratory exposure</strong> to high concentrations of live rabies virus, <strong>antibody testing</strong> should be done every <strong>6</strong> <strong>months</strong>. Those professionals who are not at continual risk of exposure through their activities, such as certain categories of <strong>veterinarians</strong> and <strong>animal health officers</strong>, should have serological monitoring every <strong>2 years. The booster</strong> would be recommended only if rabies virus-neutralizing antibody titers fall to <strong>&lt;0.5 IU/ml.</strong></p><hr><h3>Related Pearl: Rabies vaccines and immunoglobulins schedules</h3><p>According to the Ministry of Health and Family Welfare, Government of India:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f49dfa01d9bd424db725e4ebf600cb98x1280x3397.JPEG\" alt=\"Pearl Image\"><p>WHO category <strong>II</strong> or <strong>III</strong> exposures should receive&nbsp;<strong>post-exposure prophylaxis&nbsp;</strong>(PEP)<strong>&nbsp;immediately.</strong></p>\n<p>One <strong>intradermal&nbsp;</strong>(ID)&nbsp;dose is <strong>0.1 mL</strong> of vaccine and one <strong>intramuscular</strong> (IM) dose is an <strong>entire vial</strong> of vaccine, irrespective of the vial size.</p>\n<p>Should a vaccine dose be delayed for any reason, the PEP schedule should be resumed (not restarted).</p>\n<p><strong>Rabies Immunoglobulin(RIG):&nbsp;</strong></p>\n<ul>\n<li>Passive immunization</li>\n<li><strong>Single-dose</strong>; after initiation of PEP and not beyond 7 days after the first dose of vaccine</li>\n<li>Max dose: <strong>hRIG - 20IU/kg ,&nbsp;</strong><strong>eRIG</strong><strong>&nbsp;- 40IU/kg </strong>body weight</li>\n<li>Vaccines should never be withheld regardless of the availability of RIG.</li>\n<li><strong>Alternatives</strong> for RIG- WHO recommends&nbsp;<strong>m</strong><strong>onoclonal antibodies&nbsp;</strong>(mAb)&nbsp;as a 'cocktail' containing at least <strong>two antibodies</strong> against the rabies virus.</li>\n</ul>\n<p>Administration of RIG:</p>\n<ul>\n<li>RIG should be administered&nbsp;<strong>into</strong> or <strong>around</strong> the <strong>wound site</strong> or sites.</li>\n<li>The&nbsp;<strong>remaining</strong> RIG, if any, should be injected <strong>IM</strong> at a site <strong>distant</strong> from the <strong>site</strong> of vaccine administration.</li>\n<li>RIG may be diluted to a volume sufficient for all wounds to be effectively and safely infiltrated.</li>\n</ul>\n<p>Prioritization&nbsp;of RIG allocation (numbered according to priority order):</p>\n<ol>\n<li>Multiple bites</li>\n<li>Deep wounds</li>\n<li>Bites to head, neck, and hands</li>\n<li>Patients with severe immunodeficiency</li>\n<li>Confirmed/probable rabies in biting animal</li>\n<li>Bites, scratches, and exposure of mucous membranes caused by a bat</li>\n</ol>\n<p><strong>Pre-exposure prophylaxis&nbsp;(PrEP)</strong></p>\n<p>PrEP is considered in the following conditions:</p>\n<ul>\n<li>High-risk groups- laboratory staff, wildlife wardens, veterinarians, animal handlers, and travelers to endemic regions.</li>\n<li>Remote, rabies-endemic areas where access to PEP is difficult</li>\n<li>Areas where&nbsp;dog bite incidence is &gt;5% per year</li>\n<li>Areas where vampire bat rabies is known to be present.</li>\n</ul>\n<p>Pre-exposure rabies vaccination consists of <strong>3&nbsp;intramuscular (IM) or 3 intradermal (ID)</strong>&nbsp;doses. These are given on <strong>days 0, 7 and 21 or 28.</strong></p>\n<ul>\n<li>Adults - the vaccine should always be administered in the deltoid area of the arm</li>\n<li>Young children (under 1 year of age)- Administration into the anterolateral area of the thigh is recommended.</li>\n<li><strong>Rabies vaccine </strong>should<strong> never</strong> be administered in the<strong> gluteal area.</strong>&nbsp;Administration in this manner will result in <strong>lower neutralizing antibody titers.</strong></li>\n</ul>\n<p>For exposed or re-exposed patients who can document previous completion of PEP or PrEP the following guidelines would be applicable:</p>\n<ul>\n<li>Proper wound management should be done.</li>\n<li>There is no need for the administration of RIG.</li>\n<li>One site ID or IM vaccine administration on days 0 and 3.</li>\n</ul>\n<p>Only adequate wound washing would be required in case of re-exposure where the animal bite victim has documented proof of complete PEP&nbsp;<strong>within the last three months.</strong></p>\n<p>The following cases are treated as fresh cases and given full PEP:</p>\n<ul>\n<li>Those who have previously received full post-exposure treatment with neural tissue vaccines (NTV) or vaccines of unproven potency</li>\n<li>Those who cannot document complete PEP or PrEP treatment&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8672",
      "difficulty": "medium"
    },
    {
      "text": "A woman brought her 14-month-old child to the PHC for routine immunization. The child was born in February 2020 at home and has not received any vaccine till now due to the lockdown. The mother is apprehensive about her child's health and wants to immunize him. Which of the following vaccines can be given to the child now?<div class='question-desc-html'><ol>\n<li>OPV</li>\n<li>Measles</li>\n<li>BCG</li>\n<li>Vitamin A</li>\n<li>Pentavalent</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 3, 4, 5"
        },
        {
          "id": 2,
          "text": "1, 2, 4"
        },
        {
          "id": 3,
          "text": "2, 3, 4"
        },
        {
          "id": 4,
          "text": "1, 2, 4, 5"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The correct answer is <strong>1, 2, 4.</strong></p>\n<p>In the case of an unimmunized 14-month-old child,<strong> OPV, measles, </strong>and<strong> vitamin A vaccines </strong>can be <strong>given.</strong></p>\n<p><strong>Catch-up vaccination</strong> involves the administration of vaccines in children who have <strong>not been immunized at all </strong>(left-outs) or for children who <strong>took vaccines but could not complete the course </strong>(dropouts).</p>\n<p>According to the National Immunization Schedule, <strong>BCG</strong> can only be given up to <strong>1 year</strong> of age. </p>\n<p><strong>OPV</strong> can be given<strong> till 5 years</strong> of age.</p>\n<p><strong>Measles</strong> can be given <strong>till 5 years</strong> of age.</p>\n<p><strong>DPT</strong> can be given<strong> until 7 years</strong> of age (with booster doses).</p>\n<p>Only the above-mentioned vaccines have upper age limits. </p>\n<p>For pentavalent, IPV, PCV, and rotavirus vaccines, if at least one dose is given before one year of age, then remaining doses can be administered and the schedule must be completed irrespective of the age of the child. <strong>If the first dose is not administered before one year of age</strong>, then these vaccines <strong>cannot be administered to the child under UIP.</strong></p><hr><h3>Related Pearl: National Immunization Schedule (India)</h3><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>When to give</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Route</strong></td>\n<td><strong>Site</strong></td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Pregnant Women</strong></td>\n</tr>\n<tr>\n<td>Td-1</td>\n<td>\n<p>Early in pregnancy</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-2</td>\n<td>\n<p>4 weeks after Td-1*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td- Booster</td>\n<td>\n<p>If received 2 Td doses in a pregnancy <br />within the last 3 yrs*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Infants</strong></td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>At birth or as early as possible until one year of age</p>\n</td>\n<td>0.1 mL (0.05 mL until<br />1 month<br />age)</td>\n<td>Intra-dermal</td>\n<td>Left upper arm</td>\n</tr>\n<tr>\n<td>Hepatitis B - Birth Dose</td>\n<td>\n<p>At birth or as early as possible within 24 hrs</p>\n</td>\n<td>0.5 mL</td>\n<td> Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>OPV - 0</td>\n<td>\n<p>At birth or as early as possible within the first 15 days</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>OPV-1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until 5 years of age)</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>Pentavalent 1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>0.5 mL</td>\n<td>lntra·muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>Rotavirus</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>5 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>IPV</td>\n<td>\n<p>Two fractional doses at 6, 14 weeks </p>\n</td>\n<td>0.1 mL</td>\n<td>Intra-dermal two fractional dose</td>\n<td>Intra-dermal: right Upper arm (at 6, 14 weeks)<br /><br /></td>\n</tr>\n<tr>\n<td>\n<p>PCV</p>\n<p>(wherever applicable)</p>\n</td>\n<td>\n<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra·muscular</td>\n<td>Antero-lateral side of mid-thigh, right</td>\n</tr>\n<tr>\n<td>Measles/MR 1<sup>st</sup> Dose</td>\n<td>\n<p>9 completed months to 12 months<br />(Can be given till 5 years of age)</p>\n</td>\n<td>0.5ml</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm</td>\n</tr>\n<tr>\n<td>JE- 1**</td>\n<td>\n<p>9 completed months to 12 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular(killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>\n<p>Anterolateral aspect of mid-thigh/Left upper arm </p>\n</td>\n</tr>\n<tr>\n<td>Vitamin A<br />(1st dose)</td>\n<td>\n<p>At 9 completed months with measles Rubella</p>\n</td>\n<td>1 mL (1 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Children </strong></td>\n</tr>\n<tr>\n<td>DPT booster-1</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh  </td>\n</tr>\n<tr>\n<td>Measles / MR 2<sup>nd </sup>dose</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm  </td>\n</tr>\n<tr>\n<td>OPV booster</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>JE-2</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular (killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>Anterolateral aspect of mid-thigh/Left upper arm </td>\n</tr>\n<tr>\n<td>Vitamin A***<br />(2nd to 9<sup>th</sup> dose)</td>\n<td>\n<p>16–18 months, followed by one dose every 6 months up to the age of 5 years</p>\n</td>\n<td>2 mL (2 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>DPT booster 2</td>\n<td>\n<p>5–6 years</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td</td>\n<td>10 years &amp; 16 years</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>\n<p>Upper arm</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>\n<p>**JE vaccine is introduced in select endemic districts after the campaigns. Intramuscular (killed inactivated) vaccine is gradually replacing the live attenuated vaccine. This change is because the killed vaccines are more effective and require fewer doses.</p>\n<p>***The 2nd to 9th doses of vitamin A can be administered to children 1–5 years old during biannual rounds, in collaboration with ICDS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD8280",
      "difficulty": "medium"
    },
    {
      "text": "You should recommend only 1 booster Td dose to a pregnant woman if pregnancy occurs within _____ years of the last pregnancy and 2 Td doses were received.\n(Choose the best possible option)",
      "choices": [
        {
          "id": 1,
          "text": "5"
        },
        {
          "id": 2,
          "text": "1"
        },
        {
          "id": 3,
          "text": "3"
        },
        {
          "id": 4,
          "text": "7"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>You should recommend only <strong>1 booster</strong> Td dose to a pregnant woman if <strong>pregnancy occurs within 3 years of the last pregnancy</strong> and <strong>2 Td doses were received.</strong></p>\n<p>The Tetanus and adult diphtheria (Td) vaccine is a combination of tetanus and diphtheria with a lower concentration of diphtheria antigen (d) as recommended for older children and adults. The MoHFW recommends the replacement of the TT vaccine with the Td vaccine for all age groups, including pregnant women. A dose of 0.5 mL is administered via the intramuscular route in the upper arm.</p>\n<p>Scheduled to be administered at <strong>10 and 16 years of age</strong>.</p>\n<p>For pregnant women :</p>\n<ul>\n<li>Td-1: early in pregnancy</li>\n<li>Td-2: 4 weeks after Td-1</li>\n<li>Td (Booster): if pregnancy occurs within 3 years of the last pregnancy and 2 Td doses were received.</li>\n</ul><hr><h3>Related Pearl: National Immunization Schedule (India)</h3><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>When to give</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Route</strong></td>\n<td><strong>Site</strong></td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Pregnant Women</strong></td>\n</tr>\n<tr>\n<td>Td-1</td>\n<td>\n<p>Early in pregnancy</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-2</td>\n<td>\n<p>4 weeks after Td-1*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td- Booster</td>\n<td>\n<p>If received 2 Td doses in a pregnancy <br />within the last 3 yrs*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Infants</strong></td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>At birth or as early as possible until one year of age</p>\n</td>\n<td>0.1 mL (0.05 mL until<br />1 month<br />age)</td>\n<td>Intra-dermal</td>\n<td>Left upper arm</td>\n</tr>\n<tr>\n<td>Hepatitis B - Birth Dose</td>\n<td>\n<p>At birth or as early as possible within 24 hrs</p>\n</td>\n<td>0.5 mL</td>\n<td> Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>OPV - 0</td>\n<td>\n<p>At birth or as early as possible within the first 15 days</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>OPV-1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until 5 years of age)</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>Pentavalent 1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>0.5 mL</td>\n<td>lntra·muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>Rotavirus</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>5 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>IPV</td>\n<td>\n<p>Two fractional doses at 6, 14 weeks </p>\n</td>\n<td>0.1 mL</td>\n<td>Intra-dermal two fractional dose</td>\n<td>Intra-dermal: right Upper arm (at 6, 14 weeks)<br /><br /></td>\n</tr>\n<tr>\n<td>\n<p>PCV</p>\n<p>(wherever applicable)</p>\n</td>\n<td>\n<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra·muscular</td>\n<td>Antero-lateral side of mid-thigh, right</td>\n</tr>\n<tr>\n<td>Measles/MR 1<sup>st</sup> Dose</td>\n<td>\n<p>9 completed months to 12 months<br />(Can be given till 5 years of age)</p>\n</td>\n<td>0.5ml</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm</td>\n</tr>\n<tr>\n<td>JE- 1**</td>\n<td>\n<p>9 completed months to 12 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular(killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>\n<p>Anterolateral aspect of mid-thigh/Left upper arm </p>\n</td>\n</tr>\n<tr>\n<td>Vitamin A<br />(1st dose)</td>\n<td>\n<p>At 9 completed months with measles Rubella</p>\n</td>\n<td>1 mL (1 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Children </strong></td>\n</tr>\n<tr>\n<td>DPT booster-1</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh  </td>\n</tr>\n<tr>\n<td>Measles / MR 2<sup>nd </sup>dose</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm  </td>\n</tr>\n<tr>\n<td>OPV booster</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>JE-2</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular (killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>Anterolateral aspect of mid-thigh/Left upper arm </td>\n</tr>\n<tr>\n<td>Vitamin A***<br />(2nd to 9<sup>th</sup> dose)</td>\n<td>\n<p>16–18 months, followed by one dose every 6 months up to the age of 5 years</p>\n</td>\n<td>2 mL (2 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>DPT booster 2</td>\n<td>\n<p>5–6 years</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td</td>\n<td>10 years &amp; 16 years</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>\n<p>Upper arm</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>\n<p>**JE vaccine is introduced in select endemic districts after the campaigns. Intramuscular (killed inactivated) vaccine is gradually replacing the live attenuated vaccine. This change is because the killed vaccines are more effective and require fewer doses.</p>\n<p>***The 2nd to 9th doses of vitamin A can be administered to children 1–5 years old during biannual rounds, in collaboration with ICDS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5896",
      "difficulty": "easy"
    },
    {
      "text": "Match the following vaccines to the vaccine strains.<div class='question-desc-html'><p>&nbsp; &nbsp;&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>1. Yellow fever &nbsp; &nbsp; </td>\n<td>A) 14-14-2 strain</td>\n</tr>\n<tr>\n<td>2.&nbsp;Rubella &nbsp;</td>\n<td>B) 17D strain</td>\n</tr>\n<tr>\n<td>3.&nbsp;Chicken Pox&nbsp;</td>\n<td>C) RA 27/3 strain &nbsp;</td>\n</tr>\n<tr>\n<td>4.&nbsp;Japanese encephalitis</td>\n<td>D) OKA strain</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-B, 2-C, 3-A, 4-D"
        },
        {
          "id": 2,
          "text": "1-B, 2-A, 3-C, 4-D"
        },
        {
          "id": 3,
          "text": "1-B, 2-C, 3-D, 4-A"
        },
        {
          "id": 4,
          "text": "1-C, 2-D, 3-A, 4-B"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The correct match is</p>\n<table>\n<tbody>\n<tr>\n<td>1. Yellow fever &nbsp; &nbsp;</td>\n<td>B) 17D strain</td>\n</tr>\n<tr>\n<td>2.&nbsp;Rubella &nbsp;</td>\n<td>C) RA 27/3 strain &nbsp;</td>\n</tr>\n<tr>\n<td>3.&nbsp;Chicken Pox&nbsp;</td>\n<td>D) OKA strain</td>\n</tr>\n<tr>\n<td>4.&nbsp;Japanese encephalitis</td>\n<td>A) 14-14-2 strain</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Vaccines and their Strains</h3><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td>\n<p><strong>Strains</strong></p>\n</td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>Danish-1331 strain</p>\n</td>\n</tr>\n<tr>\n<td>OPV/IPV</td>\n<td>\n<p>Bivalent OPV</p>\n</td>\n</tr>\n<tr>\n<td>Measles</td>\n<td>\n<ul>\n<li>Edmonston Zagreb strain</li>\n<li>Schwartz strain</li>\n<li>Moraten strain</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Mumps</td>\n<td>\n<p>Jeryll-Lynn strain</p>\n</td>\n</tr>\n<tr>\n<td>Rubella</td>\n<td>\n<p>RA 27/3</p>\n</td>\n</tr>\n<tr>\n<td>Yellow fever</td>\n<td>\n<p>17D strain&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Varicella</td>\n<td>\n<p>OKA strain&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Japanese encephalitis</td>\n<td>\n<ul>\n<li>Nakayama strain</li>\n<li>Beijing P3 Strain</li>\n<li>SA-14-14-2 strain(used in India)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Swine flu vaccine</td>\n<td>\n<p>A7/ California / 2009&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>HIV vaccine</td>\n<td>\n<ul>\n<li>mVA strain</li>\n<li>rAAV strain</li>\n<li>CTL strain</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Malaria vaccine</td>\n<td>\n<ul>\n<li>SPf 66 strain ( Lytic cocktail)</li>\n<li>Pf 25 strain</li>\n<li>RTS,S/AS01 is effective against <em>P. falciparum.</em>\n<ul>\n<li>Phase 3 trial of this vaccine is complete.</li>\n<li>Phase 4 trial is under evaluation.</li>\n</ul>\n</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8660",
      "difficulty": "easy"
    },
    {
      "text": "A child presents at 6 weeks of age for vaccination and the clinician decides to give a combination vaccine of diphtheria, pertussis, and tetanus toxoid. How does this affect the body's immune response against tetanus toxoid compared to if it was given alone?",
      "choices": [
        {
          "id": 1,
          "text": "Remains the same whether given alone or in combination as DTP"
        },
        {
          "id": 2,
          "text": "Decreases as the immune system is divided to make antibodies against 3 antigens instead of one"
        },
        {
          "id": 3,
          "text": "Increases as multiple antigens increases the immune response"
        },
        {
          "id": 4,
          "text": "Cannot be predicted"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>immune response</strong> against the tetanus toxoid <strong>increases</strong> if given as a <strong>combination of DTP</strong> when compared to given singly.</p>\n<p>Since this vaccine is given for the first time, the response to tetanus toxoid would be enhanced. If it was given to an older child with a history of other vaccinations, immune response would differ.</p>\n<p>The immune response is variable in response to multiple antigens depending on the <strong>antigenic competition</strong>.</p>\n<ul>\n<li>If 2 bacterial vaccines (say cholera and typhoid) are given, antibodies are produced as if they are given separately.</li>\n<li>If 2 toxoids (say tetanus and diphtheria) are given with one in excess, the antibody response to the other is diminished</li>\n<li>If a toxoid is given with a bacterial vaccine (say DTP vaccine), the antibody response to the toxoid is potentiated</li>\n<li>If a toxoid is administered earlier (say diphtheria toxoid), and then later given as a triple vaccine (DTP), the antibody response to the pertussis and tetanus antigens will be diminished.</li>\n</ul>\n<p>Other factors may also play a role in antibody response:</p>\n<ul>\n<li>Size and number of doses - a minimum critical dose is required, to elicit a response against an antigen. It increases with an increase in dose, up to a certain point, after which it rather induces tolerance.</li>\n<li>Route of administration- parenteral route induces a better antibody response compared to the oral or nasal route.</li>\n</ul><hr><h3>Related Pearl: National Immunization Schedule (India)</h3><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>When to give</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Route</strong></td>\n<td><strong>Site</strong></td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Pregnant Women</strong></td>\n</tr>\n<tr>\n<td>Td-1</td>\n<td>\n<p>Early in pregnancy</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-2</td>\n<td>\n<p>4 weeks after Td-1*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td- Booster</td>\n<td>\n<p>If received 2 Td doses in a pregnancy <br />within the last 3 yrs*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Infants</strong></td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>At birth or as early as possible until one year of age</p>\n</td>\n<td>0.1 mL (0.05 mL until<br />1 month<br />age)</td>\n<td>Intra-dermal</td>\n<td>Left upper arm</td>\n</tr>\n<tr>\n<td>Hepatitis B - Birth Dose</td>\n<td>\n<p>At birth or as early as possible within 24 hrs</p>\n</td>\n<td>0.5 mL</td>\n<td> Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>OPV - 0</td>\n<td>\n<p>At birth or as early as possible within the first 15 days</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>OPV-1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until 5 years of age)</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>Pentavalent 1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>0.5 mL</td>\n<td>lntra·muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>Rotavirus</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>5 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>IPV</td>\n<td>\n<p>Two fractional doses at 6, 14 weeks </p>\n</td>\n<td>0.1 mL</td>\n<td>Intra-dermal two fractional dose</td>\n<td>Intra-dermal: right Upper arm (at 6, 14 weeks)<br /><br /></td>\n</tr>\n<tr>\n<td>\n<p>PCV</p>\n<p>(wherever applicable)</p>\n</td>\n<td>\n<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra·muscular</td>\n<td>Antero-lateral side of mid-thigh, right</td>\n</tr>\n<tr>\n<td>Measles/MR 1<sup>st</sup> Dose</td>\n<td>\n<p>9 completed months to 12 months<br />(Can be given till 5 years of age)</p>\n</td>\n<td>0.5ml</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm</td>\n</tr>\n<tr>\n<td>JE- 1**</td>\n<td>\n<p>9 completed months to 12 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular(killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>\n<p>Anterolateral aspect of mid-thigh/Left upper arm </p>\n</td>\n</tr>\n<tr>\n<td>Vitamin A<br />(1st dose)</td>\n<td>\n<p>At 9 completed months with measles Rubella</p>\n</td>\n<td>1 mL (1 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Children </strong></td>\n</tr>\n<tr>\n<td>DPT booster-1</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh  </td>\n</tr>\n<tr>\n<td>Measles / MR 2<sup>nd </sup>dose</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm  </td>\n</tr>\n<tr>\n<td>OPV booster</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>JE-2</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular (killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>Anterolateral aspect of mid-thigh/Left upper arm </td>\n</tr>\n<tr>\n<td>Vitamin A***<br />(2nd to 9<sup>th</sup> dose)</td>\n<td>\n<p>16–18 months, followed by one dose every 6 months up to the age of 5 years</p>\n</td>\n<td>2 mL (2 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>DPT booster 2</td>\n<td>\n<p>5–6 years</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td</td>\n<td>10 years &amp; 16 years</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>\n<p>Upper arm</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>\n<p>**JE vaccine is introduced in select endemic districts after the campaigns. Intramuscular (killed inactivated) vaccine is gradually replacing the live attenuated vaccine. This change is because the killed vaccines are more effective and require fewer doses.</p>\n<p>***The 2nd to 9th doses of vitamin A can be administered to children 1–5 years old during biannual rounds, in collaboration with ICDS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7008",
      "difficulty": "medium"
    }
  ]
}